Where I see patients (2)
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma PatientsTreated With Immune Checkpoint Inhibitors or Enfortumab Vedotin.
Clinical genitourinary cancer
Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer.
Frontiers in oncology
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.